Brief: New England Journal Of Medicine To Publish Results From Savara’S Phase 3 Impala-2 Clinical Trial In Autoimmune Pulmonary Alveolar Proteinosis
20/08/2025 22:26
Aug 20 (Reuters) - Savara Inc SVRA.O: NEW ENGLAND JOURNAL OF MEDICINE (NEJM) TO PUBLISH RESULTS FROM SAVARA’S PIVOTAL PHASE 3 IMPALA-2 CLINICAL TRIAL IN AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS (AUTOIMMUNE PAP) Source text: ID:nBw7Zf9kZa Further company coverage: SVRA.O ((Reuters.Briefs@thomsonreuters.com;))